Analytical Lens: Exploring Integra Lifesciences Holdings Corp (IART)’s Financial Story Through Ratios

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Integra Lifesciences Holdings Corp (NASDAQ: IART) was $26.70 for the day, up 7.19% from the previous closing price of $24.91. In other words, the price has increased by $7.19 from its previous closing price. On the day, 1.73 million shares were traded. IART stock price reached its highest trading level at $26.96 during the session, while it also had its lowest trading level at $25.57.

Ratios:

Our analysis of IART’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 54.16. For the most recent quarter (mrq), Quick Ratio is recorded 0.73 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 1.31 whereas as Long-Term Debt/Eq ratio is at 0.90.

On July 30, 2024, Citigroup Downgraded its rating to Sell which previously was Neutral and also lowered its target price recommendation from $30 to $23.

BTIG Research Downgraded its Neutral to Sell on July 30, 2024, while the target price for the stock was maintained at $22.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 19 ’24 when Mosebrook Jeffrey sold 1,191 shares for $21.58 per share. The transaction valued at 25,701 led to the insider holds 36,088 shares of the business.

ESSIG STUART bought 52,641 shares of IART for $1,499,979 on May 23 ’24. The Exec. Chairman of the Board now owns 487,922 shares after completing the transaction at $28.49 per share. On May 21 ’24, another insider, HILL BARBARA B, who serves as the Director of the company, bought 36,350 shares for $27.40 each. As a result, the insider paid 995,816 and bolstered with 36,350 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IART now has a Market Capitalization of 2060265600 and an Enterprise Value of 3774061056. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.32 while its Price-to-Book (P/B) ratio in mrq is 1.35. Its current Enterprise Value per Revenue stands at 2.412 whereas that against EBITDA is 11.68.

Stock Price History:

Over the past 52 weeks, IART has reached a high of $45.42, while it has fallen to a 52-week low of $16.81. The 50-Day Moving Average of the stock is 41.30%, while the 200-Day Moving Average is calculated to be -5.98%.

Shares Statistics:

IART traded an average of 945.08K shares per day over the past three months and 1148570 shares per day over the past ten days. A total of 78.17M shares are outstanding, with a floating share count of 65.08M. Insiders hold about 16.12% of the company’s shares, while institutions hold 89.98% stake in the company. Shares short for IART as of 1728950400 were 5113502 with a Short Ratio of 5.41, compared to 1726185600 on 4569757. Therefore, it implies a Short% of Shares Outstanding of 5113502 and a Short% of Float of 7.7.

Most Popular